Vanda Pharmaceuticals
VNDA | NASDAQ
$3.81
-$0.18 (-4.51%)
At close: Nov 16, 2026, 4:00 PM ET
$3.81
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.51%
(1D)No price chart data available for 1D timeframe.
Rating
41.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #482/1021 (Top 47%)
Key Statistics
Market Data
Market Cap $230.39M
1D Range
3.74 3.97
52W Range
3.59 9.56
Valuation (TTM)
PE -0.82
PB 1.15
EV/EBITDA -0.69
Valuation (NTM)
Forward PE N/A
Forward PEG 0.16
Price Target $10.00
Cash Flow
FCF Yield -60.8%
SBC Adj. FCF Yield -64.8%
SBC Impact -6.6%
Margins
Gross Margin 92.7%
Operating Margin -77.6%
FCF Margin -61.0%
Growth (CAGR)
Revenue 3Y | 5Y 2.7% |
-3.1%
Dil EPS 3Y | 5Y -103.0% |
-92.4%
FCF 3Y | 5Y -75.8% |
-145.5%
Returns
ROA -71.9%
ROE -106.9%
ROIC -76.7%
Financial Health
Net Cash
$135.82M
Current Ratio 1.54
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two ...
Sector Healthcare
Industry Biotechnology
Employees 533
IPO Date Apr 12, 2006
Website www.vandapharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 28, 2026
EPS
-$0.37
Beat +45.75%
YoY:
+2.63% REV
$69.82M
Beat +0.89%
YoY:
+24.10%Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$10.00
Upside
+162.47%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove VNDA